Cefoperazone & Tazobactam Injection

Cefoperazone & Tazobactam Injection

Categories : Anti-Infectives

Product Packaging : 1 vial

Product Composition : 1125 mg

Send Message

Genliva Wellness LLP formulates Cefoperazone & Tazobactam Injection for aggressive bacterial infections requiring higher antibacterial strength in hospital and intensive care environments. The injection is widely administered in ventilator-associated pneumonia, septicemia, abdominal infections, complicated urinary tract infections, and post-operative bacterial complications.

Cefoperazone attacks susceptible bacterial pathogens by disrupting bacterial cell wall formation, while Tazobactam blocks beta-lactamase enzymes responsible for bacterial resistance. The combination is frequently selected in critical infection cases where resistant bacterial organisms are suspected.

Genliva Wellness LLP manufactures sterile injectable antibiotic formulations under controlled production systems for hospital procurement programs, institutional pharmaceutical supply, and advanced critical care treatment requirements.

Cefoperazone & Tazobactam Injection combines cephalosporin and beta-lactamase inhibitor activity for hospital antibacterial therapy.

  • Sterile injectable antibiotic combination
  • Developed for resistant bacterial conditions
  • Frequently administered in ICU treatment protocols
  • High-potency antibacterial injection profile
  • Produced under strict sterile manufacturing conditions
  • Intended for critical care antibacterial applications

This injectable formulation is prescribed in severe hospital bacterial infections.

  • Treatment of septicemia and ventilator-associated pneumonia
  • Management of complicated urinary tract infections
  • Administered in abdominal bacterial infections
  • Used in post-surgical infection therapies
  • Targets resistant hospital-acquired bacteria
  • Prescribed in critical care antibacterial regimens

Cefoperazone & Tazobactam Injection delivers enhanced antibacterial coverage in severe infections.

  • Controls beta-lactamase producing bacterial strains
  • Valuable in ICU infection management
  • Rapid injectable administration during emergencies
  • Extended antibacterial reach in critical conditions
  • Combines dual-action antibacterial mechanisms
  • Frequently utilized in hospital antibiotic protocols

whatsapp-app